Lallemand Health Solutions

Fermalac vaginal

Unique vaginal combination, for a vaginal microbiota balance

3 human clinical studies in vaginal microflora balance

Fermalac^®Vaginal is a unique combination of Yogurt culture and Lactobacillus rhamnosus Rosell^®–11 probotic strains.

Fermalac^® Vaginal is supported by 3 human clinical studies performed in 170 participants with bacterial vaginosis. The probiotic combination, in conjunction with standard therapy: restores the vaginal microflora and decreases the recurrence rate in Bacterial Vaginosis.

© 2024 Lallemand Inc. All right reserved.
The information contained herein is business-to-business information and is not intended for the final consumer. It is based on our research and development work and is, to the best of our knowledge, reliable. Lallemand Health Solutions does not assume any liability resulting from the use of its products, as conditions of use are beyond our control. The business-to-business information provided should not be used as a substitute for any form of advice. In all instances, producers and marketers should check local regulatory requirements before use as different claims may be made depending on the regulations applicable in each country.